The PE Ratio as of September 2024 (TTM) for Tempest Therapeutics, Inc. (TPST) is -0.77

According to Tempest Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.77. This represents a change of -63.36% compared to the average of -2.10 of the last 4 quarters.

Tempest Therapeutics, Inc. (TPST) Historical PE Ratio (quarterly & annually)

How has TPST PE Ratio performed in the past?

The mean historical PE Ratio of Tempest Therapeutics, Inc. over the last ten years is -3.04. The current -0.77 PE Ratio has changed 2.44% with respect to the historical average. Over the past ten years (40 quarters), TPST's PE Ratio was at its highest in in the September 2023 quarter at -0.16. The PE Ratio was at its lowest in in the December 2014 quarter at -15.92.

Tempest Therapeutics, Inc. (TPST) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Tempest Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tempest Therapeutics, Inc. (TPST) Average PE Ratio

How has TPST PE Ratio performed in the past?

The current PE Ratio of Tempest Therapeutics, Inc. (TPST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tempest Therapeutics, Inc. (TPST) PE Ratio vs. Peers

How is TPST’s PE Ratio compared to its peers?

Tempest Therapeutics, Inc.’s PE Ratio is greater than Indaptus Therapeutics, Inc. (-0.78), greater than Rezolute, Inc. (-3.80), less than Comera Life Sciences Holdings, Inc. (-0.01), less than Forte Biosciences, Inc. (-0.39), greater than Sana Biotechnology, Inc. (-4.82), greater than Olema Pharmaceuticals, Inc. (-6.07), greater than Cullinan Oncology, Inc. (-6.96), greater than aTyr Pharma, Inc. (-2.33), greater than Zentalis Pharmaceuticals, Inc. (-1.08), greater than Lyell Immunopharma, Inc. (-1.42), greater than Monte Rosa Therapeutics, Inc. (-3.11), greater than Theseus Pharmaceuticals, Inc. (-3.19), greater than Revolution Medicines, Inc. (-13.31), greater than ZIVO Bioscience, Inc. (-2.46), greater than RenovoRx, Inc. (-3.02), greater than Ikena Oncology, Inc. (-1.22), less than Catalyst Biosciences, Inc. (-0.44), greater than Akari Therapeutics, Plc (-1.55), greater than Armata Pharmaceuticals, Inc. (-1.26), greater than Anebulo Pharmaceuticals, Inc. (-4.99), less than Scopus BioPharma Inc. (-0.00), less than Processa Pharmaceuticals, Inc. (-0.37),

Build a custom stock screener for Tempest Therapeutics, Inc. (TPST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tempest Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tempest Therapeutics, Inc. (TPST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tempest Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.